- Report
- July 2022
- 122 Pages
United Kingdom
From €3090EUR$3,450USD£2,712GBP
- Report
- April 2025
- 139 Pages
From €3090EUR$3,450USD£2,712GBP
- Report
- January 2025
- 73 Pages
From €3090EUR$3,450USD£2,712GBP
- Report
- August 2024
- 200 Pages
Global
From €3986EUR$4,450USD£3,498GBP
- Report
- November 2023
- 160 Pages
Global
From €3986EUR$4,450USD£3,498GBP
- Report
- July 2023
- 220 Pages
From €3090EUR$3,450USD£2,712GBP
- Report
- July 2023
- 224 Pages
North America
From €3090EUR$3,450USD£2,712GBP
- Report
- July 2023
- 230 Pages
Africa, Middle East
From €3090EUR$3,450USD£2,712GBP
- Report
- July 2023
- 253 Pages
Europe
From €3090EUR$3,450USD£2,712GBP
- Report
- June 2023
- 250 Pages
Asia Pacific
From €3090EUR$3,450USD£2,712GBP
- Report
- October 2022
- 209 Pages
Global
From €3986EUR$4,450USD£3,498GBP
- Report
- September 2022
- 157 Pages
Europe
From €3090EUR$3,450USD£2,712GBP
- Report
- September 2022
- 181 Pages
Asia Pacific
From €3090EUR$3,450USD£2,712GBP
- Report
- August 2022
- 124 Pages
Asia Pacific
From €3090EUR$3,450USD£2,712GBP
- Report
- July 2022
- 132 Pages
Europe
From €3090EUR$3,450USD£2,712GBP
- Report
- March 2022
- 198 Pages
Global
From €3986EUR$4,450USD£3,498GBP
- Report
- February 2022
- 174 Pages
Global
From €3986EUR$4,450USD£3,498GBP
- Report
- January 2024
- 150 Pages
Global
From €3448EUR$3,850USD£3,026GBP
€4344EUR$4,850USD£3,812GBP
- Report
- November 2025
- 150 Pages
China
From €3448EUR$3,850USD£3,026GBP
- Report
- November 2025
- 150 Pages
China
From €3448EUR$3,850USD£3,026GBP

The biopharmaceuticals market is a sector of the pharmaceutical industry that focuses on the development and production of drugs derived from biological sources. These drugs are typically produced using recombinant DNA technology, which involves the manipulation of genetic material to create proteins and other molecules with therapeutic properties. Biopharmaceuticals are used to treat a wide range of diseases, including cancer, HIV/AIDS, and autoimmune disorders.
Biopharmaceuticals are typically more expensive to produce than traditional pharmaceuticals, but they offer a number of advantages, such as improved efficacy and fewer side effects. They are also more targeted, meaning they can be used to treat specific conditions more effectively.
Some of the major companies in the biopharmaceuticals market include Amgen, Biogen, Celgene, Gilead Sciences, and Novartis. These companies are involved in the development and production of a wide range of biopharmaceuticals, including monoclonal antibodies, vaccines, and gene therapies. Show Less Read more